Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-up
Lenalidomide and dexamethasone (RD) is a standard treatment in relapsed/refractory immunoglobulin light chain (AL) amyloidosis (RRAL). We retrospectively investigated toxicity, efficacy and prognostic markers in 260 patients with RRAL. Patients received a median of two prior treatment lines (68% had...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
3 August 2021
|
| In: |
British journal of haematology
Year: 2021, Jahrgang: 195, Heft: 2, Pages: 230-243 |
| ISSN: | 1365-2141 |
| DOI: | 10.1111/bjh.17685 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1111/bjh.17685 Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17685 
|
| Verfasserangaben: | Marco Basset, Christoph R. Kimmich, Nicholas Schreck, Julia Krzykalla, Tobias Dittrich, Kaya Veelken, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Anna Jauch, Carsten Müller-Tidow, Axel Benner, Ute Hegenbart, and Stefan O. Schönland |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1856121968 | ||
| 003 | DE-627 | ||
| 005 | 20240306115646.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230814s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjh.17685 |2 doi | |
| 035 | |a (DE-627)1856121968 | ||
| 035 | |a (DE-599)KXP1856121968 | ||
| 035 | |a (OCoLC)1425063174 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Basset, Marco |e VerfasserIn |0 (DE-588)1248079892 |0 (DE-627)1782609199 |4 aut | |
| 245 | 1 | 0 | |a Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis |b results from a large cohort of patients with long follow-up |c Marco Basset, Christoph R. Kimmich, Nicholas Schreck, Julia Krzykalla, Tobias Dittrich, Kaya Veelken, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Anna Jauch, Carsten Müller-Tidow, Axel Benner, Ute Hegenbart, and Stefan O. Schönland |
| 264 | 1 | |c 3 August 2021 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.08.2023 | ||
| 520 | |a Lenalidomide and dexamethasone (RD) is a standard treatment in relapsed/refractory immunoglobulin light chain (AL) amyloidosis (RRAL). We retrospectively investigated toxicity, efficacy and prognostic markers in 260 patients with RRAL. Patients received a median of two prior treatment lines (68% had been bortezomib-refractory; 33% had received high-dose melphalan). The median treatment duration was four cycles. The 3-month haematological response rate was 31% [very good haematological response (VGHR) in 18%]. The median follow-up was 56·5 months and the median overall survival (OS) and haematological event-free survival (haemEFS) were 32 and 9 months. The 2-year dialysis rate was 15%. VGHR resulted in better OS (62 vs. 26 months, P < 0·001). Cardiac progression predicted worse survival (22 vs. 40 months, P = 0·027), although N-terminal prohormone of brain natriuretic peptide (NT-proBNP) increase was frequently observed. Multivariable analysis identified these prognostic factors: NT-proBNP for OS [hazard ratio (HR) 1·71; P < 0·001]; gain 1q21 for haemEFS (HR 1·68, P = 0·014), with a trend for OS (HR 1·47, P = 0·084); difference between involved and uninvolved free light chains (dFLC) and light chain isotype for OS (HR 2·22, P < 0·001; HR 1·62, P = 0·016) and haemEFS (HR 1·88, P < 0·001; HR 1·59, P = 0·008). Estimated glomerular filtration rate (HR 0·71, P = 0·004) and 24-h proteinuria (HR 1·10, P = 0·004) were prognostic for renal survival. In conclusion, clonal and organ biomarkers at baseline identify patients with favourable outcome, while VGHR and cardiac progression define prognosis during RD treatment. | ||
| 650 | 4 | |a AL amyloidosis | |
| 650 | 4 | |a biomarkers | |
| 650 | 4 | |a gain 1q21 | |
| 650 | 4 | |a lenalidomide | |
| 650 | 4 | |a prognosis | |
| 700 | 1 | |a Kimmich, Christoph |e VerfasserIn |0 (DE-588)1075478413 |0 (DE-627)833305042 |0 (DE-576)443499632 |4 aut | |
| 700 | 1 | |a Schreck, Nicholas |d 1991- |e VerfasserIn |0 (DE-588)1162142626 |0 (DE-627)1025567323 |0 (DE-576)507200314 |4 aut | |
| 700 | 1 | |a Krzykalla, Julia |d 1990- |e VerfasserIn |0 (DE-588)1233493949 |0 (DE-627)1757841563 |4 aut | |
| 700 | 1 | |a Dittrich, Tobias |d 1986- |e VerfasserIn |0 (DE-588)1075743141 |0 (DE-627)833664085 |0 (DE-576)444611495 |4 aut | |
| 700 | 1 | |a Veelken, Kaya |d 1988- |e VerfasserIn |0 (DE-588)1155327845 |0 (DE-627)1016744269 |0 (DE-576)501617655 |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Seckinger, Anja |d 1980- |e VerfasserIn |0 (DE-588)134177371 |0 (DE-627)562118225 |0 (DE-576)278603734 |4 aut | |
| 700 | 1 | |a Hose, Dirk |d 1969- |e VerfasserIn |0 (DE-588)139824995 |0 (DE-627)613790308 |0 (DE-576)313431698 |4 aut | |
| 700 | 1 | |a Jauch, Anna |d 1959- |e VerfasserIn |0 (DE-588)1025525140 |0 (DE-627)722525362 |0 (DE-576)168357496 |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Benner, Axel |d 1959- |e VerfasserIn |0 (DE-588)106584686X |0 (DE-627)81687221X |0 (DE-576)425536602 |4 aut | |
| 700 | 1 | |a Hegenbart, Ute |e VerfasserIn |0 (DE-588)1028373708 |0 (DE-627)73062157X |0 (DE-576)35901903X |4 aut | |
| 700 | 1 | |a Schönland, Stefan |d 1969- |e VerfasserIn |0 (DE-588)122405226 |0 (DE-627)705896137 |0 (DE-576)293255792 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of haematology |d Oxford [u.a.] : Wiley-Blackwell, 1955 |g 195(2021), 2, Seite 230-243 |h Online-Ressource |w (DE-627)269758941 |w (DE-600)1475751-5 |w (DE-576)09113997X |x 1365-2141 |7 nnas |a Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis results from a large cohort of patients with long follow-up |
| 773 | 1 | 8 | |g volume:195 |g year:2021 |g number:2 |g pages:230-243 |g extent:14 |a Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis results from a large cohort of patients with long follow-up |
| 856 | 4 | 0 | |u https://doi.org/10.1111/bjh.17685 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.17685 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230814 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 122405226 |a Schönland, Stefan |m 122405226:Schönland, Stefan |d 910000 |d 910100 |d 50000 |e 910000PS122405226 |e 910100PS122405226 |e 50000PS122405226 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 14 |y j | ||
| 998 | |g 1028373708 |a Hegenbart, Ute |m 1028373708:Hegenbart, Ute |d 910000 |d 910100 |d 50000 |e 910000PH1028373708 |e 910100PH1028373708 |e 50000PH1028373708 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 13 | ||
| 998 | |g 106584686X |a Benner, Axel |m 106584686X:Benner, Axel |d 50000 |e 50000PB106584686X |k 0/50000/ |p 12 | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 11 | ||
| 998 | |g 1025525140 |a Jauch, Anna |m 1025525140:Jauch, Anna |d 910000 |d 911500 |d 50000 |e 910000PJ1025525140 |e 911500PJ1025525140 |e 50000PJ1025525140 |k 0/910000/ |k 1/910000/911500/ |k 0/50000/ |p 10 | ||
| 998 | |g 139824995 |a Hose, Dirk |m 139824995:Hose, Dirk |d 50000 |e 50000PH139824995 |k 0/50000/ |p 9 | ||
| 998 | |g 134177371 |a Seckinger, Anja |m 134177371:Seckinger, Anja |d 50000 |e 50000PS134177371 |k 0/50000/ |p 8 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |e 910000PG102258023X |e 910100PG102258023X |k 0/910000/ |k 1/910000/910100/ |p 7 | ||
| 998 | |g 1155327845 |a Veelken, Kaya |m 1155327845:Veelken, Kaya |d 910000 |d 910100 |e 910000PV1155327845 |e 910100PV1155327845 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 1075743141 |a Dittrich, Tobias |m 1075743141:Dittrich, Tobias |d 910000 |d 910100 |e 910000PD1075743141 |e 910100PD1075743141 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1233493949 |a Krzykalla, Julia |m 1233493949:Krzykalla, Julia |d 50000 |e 50000PK1233493949 |k 0/50000/ |p 4 | ||
| 998 | |g 1162142626 |a Schreck, Nicholas |m 1162142626:Schreck, Nicholas |d 50000 |e 50000PS1162142626 |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1856121968 |e 436593211X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"role":"aut","family":"Basset","roleDisplay":"VerfasserIn","display":"Basset, Marco","given":"Marco"},{"given":"Christoph","roleDisplay":"VerfasserIn","display":"Kimmich, Christoph","family":"Kimmich","role":"aut"},{"role":"aut","family":"Schreck","roleDisplay":"VerfasserIn","display":"Schreck, Nicholas","given":"Nicholas"},{"roleDisplay":"VerfasserIn","display":"Krzykalla, Julia","given":"Julia","family":"Krzykalla","role":"aut"},{"role":"aut","family":"Dittrich","given":"Tobias","roleDisplay":"VerfasserIn","display":"Dittrich, Tobias"},{"given":"Kaya","roleDisplay":"VerfasserIn","display":"Veelken, Kaya","family":"Veelken","role":"aut"},{"role":"aut","given":"Hartmut","roleDisplay":"VerfasserIn","display":"Goldschmidt, Hartmut","family":"Goldschmidt"},{"family":"Seckinger","roleDisplay":"VerfasserIn","given":"Anja","display":"Seckinger, Anja","role":"aut"},{"family":"Hose","display":"Hose, Dirk","roleDisplay":"VerfasserIn","given":"Dirk","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Jauch, Anna","given":"Anna","family":"Jauch"},{"display":"Müller-Tidow, Carsten","roleDisplay":"VerfasserIn","given":"Carsten","family":"Müller-Tidow","role":"aut"},{"display":"Benner, Axel","roleDisplay":"VerfasserIn","given":"Axel","family":"Benner","role":"aut"},{"family":"Hegenbart","roleDisplay":"VerfasserIn","display":"Hegenbart, Ute","given":"Ute","role":"aut"},{"role":"aut","family":"Schönland","display":"Schönland, Stefan","roleDisplay":"VerfasserIn","given":"Stefan"}],"title":[{"subtitle":"results from a large cohort of patients with long follow-up","title":"Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis","title_sort":"Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis"}],"id":{"eki":["1856121968"],"doi":["10.1111/bjh.17685"]},"recId":"1856121968","name":{"displayForm":["Marco Basset, Christoph R. Kimmich, Nicholas Schreck, Julia Krzykalla, Tobias Dittrich, Kaya Veelken, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Anna Jauch, Carsten Müller-Tidow, Axel Benner, Ute Hegenbart, and Stefan O. Schönland"]},"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"pages":"230-243","year":"2021","issue":"2","text":"195(2021), 2, Seite 230-243","extent":"14","volume":"195"},"titleAlt":[{"title":"the official journal of the British Society of Haematology"},{"title":"BJH ; the official journal of the British Society for Haematology"}],"title":[{"title_sort":"British journal of haematology","title":"British journal of haematology","subtitle":"BJHaem : an official journal of the British Society for Haematology"}],"id":{"doi":["10.1111/(ISSN)1365-2141"],"zdb":["1475751-5"],"eki":["269758941"],"issn":["1365-2141"]},"recId":"269758941","pubHistory":["1.1955 -"],"name":{"displayForm":["ed. R. B. Thompson [u.a.]"]},"note":["Gesehen am 08.05.08"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis results from a large cohort of patients with long follow-upBritish journal of haematology","language":["eng"],"origin":[{"dateIssuedKey":"1955","dateIssuedDisp":"1955-","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","publisherPlace":"Oxford [u.a.] ; Oxford ; Oxford [u.a.]"}],"corporate":[{"display":"British Society for Haematology","roleDisplay":"Herausgebendes Organ","role":"isb"},{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"European Hematology Association"}]}],"physDesc":[{"extent":"14 S."}],"note":["Gesehen am 14.08.2023"],"language":["eng"],"origin":[{"dateIssuedDisp":"3 August 2021","dateIssuedKey":"2021"}]} | ||
| SRT | |a BASSETMARCLENALIDOMI3202 | ||